ARS Advances Fight Against Deadly African Swine Fever Virus

At the Plum Island Animal Disease Center in Orient Point, NY, ARS microbiologists Douglas Gladue (left) and Manuel Borca work on developing candidate vaccines against African swine fever virus, which causes a lethal disease in swine.
At the Plum Island Animal Disease Center in Orient Point, NY, ARS microbiologists Douglas Gladue (left) and Manuel Borca work on developing candidate vaccines against African swine fever virus, which causes a lethal disease in swine.
(Photo by Kathleen Apicelli, PIADC)

A recent change in regulatory status may speed up commercial work on African swine fever (ASF) vaccine candidates, said Douglas Gladue, a USDA Agricultural Research Service (ARS) microbiologist at the Plum Island Animal Disease Center (PIADC).

“Three of our vaccine candidates have been removed from the Federal Select Agent list,” which is a list of agents and toxins that must be worked on in facilities with the highest level of biosafety (BSL3), he said in an ARS release.

PIADC is one of only two BSL3 facilities in the U.S. authorized to work with ASF virus. “Removal from the Select Agent list could pave the way for our vaccine candidates to be worked on in other facilities in the United States and worldwide,” Gladue said.

In the past year, ARS scientists have made two important advancements against the ASF virus. Scientists at PIADC in Orient Point, N.Y., developed several vaccine candidates by deleting genes to weaken the virus, ARS reports in a release. 

By using a gene editing technique that allows DNA to be directly inserted, deleted, modified, or replaced in the genome of a living organism, the team was able to license four different ASF vaccine candidates to commercial partners for further development, according to ARS.

The team’s second major advancement, after an intensive screening process, allowed them to identify a commercially available stable cell line for diagnostic labs to use specifically in testing for infectious ASF virus. 

“Until now, fresh swine macrophages (large white blood cells) were the only cells that would work in the diagnostic testing process. This required labs to continuously culture fresh cells so they would be ready if and when a sample arrived for testing,” ARS said in a release.

Fortunately, researchers said another cell line, from an African green monkey, not only works as well as macrophages but can also be frozen until needed, eliminating the need for continuous culturing.

“The advantage is enormous. You can keep the cell line in the freezer until you need it, and then you can have it in culture within 2 days,” said ARS microbiologist Manuel Borca.

This also will free up diagnostic labs from having to work to obtain donor pig blood and process the macrophages, he said in the release.

Being able to use the commercially available primate cell line will save time, labor, equipment and money. These cells are now available to diagnostic labs, including the Foreign Animal Disease Diagnostic Laboratory, part of USDA’s Animal and Plant Health Inspection Service.

The ASF virus has not reached the U.S., but continues to gain momentum around the globe in parts of Europe, Asia and Africa. The disease is almost always fatal in swine, although it poses no risk to humans. However, the significant economic losses and trade restrictions pose great challenges to the global swine industry.

ARS reports the research team is awaiting news on patenting a third important advancement in the fight against ASF.

Read more about ASF news at https://www.porkbusiness.com/topics/african-swine-fever.

 

Latest News

Hogs and Pigs Report: How Will Increase in Pigs Saved Per Litter Impact the Pork Outlook?
Hogs and Pigs Report: How Will Increase in Pigs Saved Per Litter Impact the Pork Outlook?

Of all the numbers in the latest USDA Hogs and Pigs Report, the number that caught economists’ eye was pigs saved per litter. Here's why Steve Meyer, Ever. Ag senior economists, says this is a number to watch.

Why You Need to Understand How USDA Purchase Programs Work
Why You Need to Understand How USDA Purchase Programs Work

With pork producers facing prolonged economic headwinds, recent USDA commodity purchases of pork offer relief at pivotal times. It’s important to understand how these programs work, says NPPC president Lori Stevermer.

Get the Facts Straight on Highly Pathogenic Avian Influenza
Get the Facts Straight on Highly Pathogenic Avian Influenza

Now that the mystery illness impacting some dairy herds has been revealed as the same strain of Highly Pathogenic Avian Influenza that has been impacting the U.S. poultry flock, pork producers are asking questions.

Merck Introduces Sequivity with Microsol Diluvac Forte Adjuvant Prescription Vaccine
Merck Introduces Sequivity with Microsol Diluvac Forte Adjuvant Prescription Vaccine

Merck Animal Health announced it has received license approval from the USDA for Sequivity with Microsol Diluvac Forte adjuvant prescription vaccine for use in gilts and sows. 

What Does the Next Generation of the Pork Industry Want?
What Does the Next Generation of the Pork Industry Want?

It’s easy to make assumptions about what others think, but recent research funded by the Indiana Pork Producers Association and the Indiana Soybean Alliance proves it’s always better to go to the source itself.

Skills Survey Reveals U.S. Agriculture & Food Industry Workforce Needs and Gaps
Skills Survey Reveals U.S. Agriculture & Food Industry Workforce Needs and Gaps

U.S. employers report challenges in finding suitable job candidates with work-ready skills to fill open roles in ag. The AgCareers.com U.S. Skills Survey offers insights, data and trends to address skill development.